Literature DB >> 3293872

Evaluation of methods of administering tyramine to raise systolic blood pressure.

D G Pace1, S B Reele, L M Rozik, C A Rogers-Phillips, J A Dabice, S V Givens.   

Abstract

To compare the relative merits of two different administration regimens, tyramine was administered intravenously in ascending doses to 12 healthy subjects to raise systolic blood pressure slightly more than 30 mm Hg. Six subjects received tyramine by bolus injection and six other subjects received tyramine by infusion. The bolus dose of tyramine needed was 4.34 +/- 1.51 mg (X +/- SD) and the infusion rate needed was 1.11 +/- 0.33 mg/min. Four blood pressure response patterns to continuous tyramine infusion were observed. Because different units were measured for the quantity of tyramine administered, the between-subject variance estimate to within-subject variance estimate ratios were calculated. The two techniques had equivalent consistency. With the bolus method, in contrast to the infusion procedure, the dose-response relationship was obvious in most subjects. Therefore the bolus method was judged to be more useful than the infusion method.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293872     DOI: 10.1038/clpt.1988.128

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  An investigation of components of variance and tachyphylaxis in a placebo-controlled intravenous tyramine study.

Authors:  M V Cantarini; C L Watkins; J Growcott; A M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Intravenous amine pressor tests in healthy volunteers. Within- and between subject variances and sex differences.

Authors:  I W Reimann; L Firkusny; K H Antonin; P R Bieck
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Effect of oral linezolid on the pressor response to intravenous tyramine.

Authors:  Mireille V Cantarini; Catherine J Painter; Elaine M Gilmore; Catherine Bolger; Claire L Watkins; Andrew M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  COMT inhibition with nitecapone does not affect the tyramine pressor response.

Authors:  S Sundberg; A Gordin
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.